These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37083067)

  • 21. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
    Tang X; Lu M; Li C; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
    J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells.
    Fan LL; Chen X; Zhang XY; Li ZM; Fan XM; Shen Y
    Med Sci Monit; 2020 Aug; 26():e922612. PubMed ID: 32829374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural compound from Garcinia bracteata mainly induces GSDME-mediated pyroptosis in esophageal cancer cells.
    Tan JQ; Li Z; Chen G; Wu M; Feng JL; Kong SY; Shi XQ; Zhang HM; Lao YZ; Zhou H; Zhang L; Xu HX
    Phytomedicine; 2022 Jul; 102():154142. PubMed ID: 35623158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice.
    Hou WJ; Guan JH; Dong Q; Han YH; Zhang R
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2902-8. PubMed ID: 24254559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma.
    Jiang M; Wu Y; Qi L; Li L; Song D; Gan J; Li Y; Ling X; Song C
    Chem Biol Interact; 2021 Dec; 350():109704. PubMed ID: 34655567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel.
    Khayrani AC; Mahmud H; Oo AKK; Zahra MH; Oze M; Du J; Alam MJ; Afify SM; Quora HAA; Shigehiro T; Calle AS; Okada N; Seno A; Fujita K; Hamada H; Seno Y; Mandai T; Seno M
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
    Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
    Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer.
    Han S; Dwivedi P; Mangrio FA; Dwivedi M; Khatik R; Cohn DE; Si T; Xu RX
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):957-967. PubMed ID: 30892967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway.
    Yanaihara N; Yoshino Y; Noguchi D; Tabata J; Takenaka M; Iida Y; Saito M; Yanagida S; Iwamoto M; Kiyokawa T; Chiba N; Okamoto A
    Gynecol Oncol; 2023 Jan; 168():83-91. PubMed ID: 36403366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
    Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P
    Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway.
    Qiao L; Wu X; Zhang J; Liu L; Sui X; Zhang R; Liu W; Shen F; Sun Y; Xi X
    FASEB J; 2019 Nov; 33(11):12760-12767. PubMed ID: 31480859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lobaplatin Induces Pyroptosis in Cervical Cancer Cells via the Caspase-3/GSDME Pathway.
    Chen J; Ge L; Shi X; Liu J; Ruan H; Heng D; Ye C
    Anticancer Agents Med Chem; 2022; 22(11):2091-2097. PubMed ID: 34666646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.
    Wang Y; Gao W; Shi X; Ding J; Liu W; He H; Wang K; Shao F
    Nature; 2017 Jul; 547(7661):99-103. PubMed ID: 28459430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer.
    Wu X; Qiu L; Feng H; Zhang H; Yu H; Du Y; Wu H; Zhu S; Ruan Y; Jiang H
    Life Sci; 2022 Mar; 293():120328. PubMed ID: 35051418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.
    Zhao H; Li Q; Hong Z
    Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy promotes GSDME-mediated pyroptosis via intrinsic and extrinsic apoptotic pathways in cobalt chloride-induced hypoxia reoxygenation-acute kidney injury.
    Liu W; Gan Y; Ding Y; Zhang L; Jiao X; Liu L; Cao H; Gu Y; Yan L; Wang Y; Wang L; Chen S; Shao F
    Ecotoxicol Environ Saf; 2022 Sep; 242():113881. PubMed ID: 35863214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer.
    Wang N; He T; Shen Y; Song L; Li L; Yang X; Li X; Pang M; Su W; Liu X; Wu Q; Gong C
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4368-77. PubMed ID: 26809267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
    Lin H; Shen L; Lin Q; Dong C; Maswela B; Illahi GS; Wu X
    Biomed Pharmacother; 2020 Mar; 123():109711. PubMed ID: 31884343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
    Zhang R; Chen X; Fu S; Xu L; Lin J
    Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.